Researchers reported that between 2011 and 2023 the largest users of semaglutide were disproportionately female, non-Hispanic white
In a statement following the EMA PRACs decision, Alison Cave, chief safety officer at the MHRA, said: We are currently reviewing safety data on the risk of suicidal thoughts and thoughts of self-harm associated with medicines known as GLP-1 receptor agonists, used for treating both type 2 diabetes and weight loss
Thus, novel intervention strategies, such as treatment using antioxidants, metabolic rescue of autolysosomal degradation, and repurposing of conventional drugs, are possible options to counteract or fine-tune the current treatment for SLE (152)
There isn't enough safety data to support ipamorelin use during pregnancy or while nursing
Khoo J, Hsiang JC, Taneja R, et al
GLP-1RA (geniposide) might be a potential therapeutic agent for GIOP ( Effects of Glucagon-Like Peptide-1 Receptor Agonists on Postmenopausal Osteoporosis In one study, liraglutide was used to treat streptozotocin (STZ)-induced diabetes and/or bilateral ovariectomy (OVX) rats for 8 weeks
